TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial

243

Citations

17

References

2012

Year

Charles Burant, Prabhakar Viswanathan, John Marcinak, Charlie Cao, Majid Vakilynejad, Benhuai Xie, Eckhard Leifke

Metabolic SyndromeDiabetes ManagementTak-875 Versus PlaceboCardiovascular DiseaseDiabetesType 2Diabetes MellitusMedicine

References

	Year	Citations

Page 1